Tag: HKEX

Stay informed on the latest legal developments shaping China's business landscape

Skadden, KWM, Appleby, Latham & Watkins and Han Kun advised on CaoCao’s HKD1.85 billion HKEX listing, marking Geely’s 10th listed company

Haitian raised HKD10.1 billion in its HKEX debut, with top firms advising on the year’s second-largest main board IPO

Clifford Chance advised on Asia’s first Saudi sukuk ETF listing on HKEX, providing Sharia-compliant investment access

Sullivan & Cromwell and Clifford Chance advise on ENN Energy’s USD11.6B privatisation, involving H shares, HKEX delisting, and regulatory compliance

Mixue Group raised HKD3.46 billion in its HKEX debut

HK Acquisition has merged with Synagistics, the first de-SPAC on the HKEX

Kirkland & Ellis is advising Edding Group on its first backdoor listing in Hong Kong with Genor Biopharma on the HKEX

Skadden, Clifford Chance, Norton Rose, and Kirkland advised on L’Occitane chairman’s brand privatisation, ending its 14-year HKEX run

A dispute resolution team from Norton Rose Fulbright has recently joined Dentons Hong Kong, including Philip Nunn, Alfred Wu, and Muriel Cheng

Clifford Chance, Zhong Lun Law Firm, Maples Group, K&L Gates, Wilson Sonsini and JunHe have advised on Black Sesame International’s IPO

Following stagnation on the GEM, the HKEX is seeking to revitalise its second board but there are concerns the revamp will crimp rather than promote activity as has occurred after the SPAC reforms

O’Melveny, Grandall, Carey Olsen, HSF and Jia Yuan assisted Tiantu Capital in completing its USD144 million IPO on HKEX, making it the first mainland PE/VC company to list in the city

Four law firms counselled China Zheshang Bank for its HKD13.8 billion (USD1.77 billion) rights issue on the HKEX and the SSE

Six law firms acted on Keep’s HKD313 million (USD40 million) IPO, marking the Chinese online fitness platform’s success

Luzhu Biotechnology debuted on the HKEX through chapter 18A, the first biotech company without any revenue or profits to be listed this year, raising USD43.45 million

Three firms advised Ping An Insurance’s fintech arm Lufax on its HKEX debut by introduction, a way for a company already on another exchange to list without issuing new shares or fundraising within six months

The HKEX has launched a consultation on lowering the bar for companies going public from five “specialist technology industries”  to generate business for the Hong Kong bourse from the rapidly evolving tech sector

China’s biggest privately owned vaccine group AIM Vaccine enlisted legal advice from Sullivan & Cromwell (S&C) and Jingtian & Gongcheng for its debut on the HKEX

A Tencent-backed Chinese drama series company, Linmon Media, has raised HKD420 million (USD53.5 million) from its IPO on the HKEX

Chinese property platform KE overcame significant hurdles to complete a dual-primary listing via introduction on the HKEX with weighted voting rights (WVR) in the first such so-called “homecoming” debut in Hong Kong

China insurance conglomerate Ping An's fintech subsidiary, OneConnect Financial Technology, has debuted on the main board of the HKEX by way of introduction and dual-primary listing

Hospitality and tourism powerhouse Jin Jiang International was advised on the privatisation of Hong Kong-listed Jin Jiang Capital by Baker McKenzie FenXun

Aquila Acquisition Corporation became the first special purpose acquisition company (SPAC) to list in Hong Kong

A property agency backed by multimedia giant Tencent has been given the go ahead for a dual-primary listing by way of introduction on the HKEX

Electric vehicle manufacturer NIO successfully listed on the main board of the HKEX by way of introduction with shares beginning trading on March 10

Under the Hong Kong regulatory framework, listed companies should focus on the following aspects of compliance.